|
C1ORF103 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.65270000000084E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.641280E-04 |
| Normal-vs-Stage2 |
4.062100E-03 |
| Normal-vs-Stage3 |
1.57169999999152E-05 |
| Normal-vs-Stage4 |
5.90229999999359E-05 |
| Stage1-vs-Stage2 |
9.302000E-01 |
| Stage1-vs-Stage3 |
7.927600E-02 |
| Stage1-vs-Stage4 |
2.187400E-01 |
| Stage2-vs-Stage3 |
4.088200E-01 |
| Stage2-vs-Stage4 |
5.380000E-01 |
| Stage3-vs-Stage4 |
8.090400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.89199999999623E-05 |
| Normal-vs-AfricanAmerican |
1.52552000000084E-05 |
| Normal-vs-Asian |
6.482400E-02 |
| Caucasian-vs-AfricanAmerican |
1.450240E-01 |
| Caucasian-vs-Asian |
5.551400E-01 |
| AfricanAmerican-vs-Asian |
8.622000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.974160E-04 |
| Normal-vs-Female |
1.25890000002293E-06 |
| Male-vs-Female |
1.247910E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.795400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.176250E-04 |
| Normal-vs-Age(61-80Yrs) |
3.90420000000447E-05 |
| Normal-vs-Age(81-100Yrs) |
9.60909999999648E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.562800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.512200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.964390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.480400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.147980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.941030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.431770E-01 |
| Normal-vs-Grade 2 |
2.388800E-04 |
| Normal-vs-Grade 3 |
4.16240000000734E-06 |
| Normal-vs-Grade 4 |
1.759110E-04 |
| Grade 1-vs-Grade 2 |
7.026000E-01 |
| Grade 1-vs-Grade 3 |
2.795400E-01 |
| Grade 1-vs-Grade 4 |
4.770800E-01 |
| Grade 2-vs-Grade 3 |
1.081600E-01 |
| Grade 2-vs-Grade 4 |
4.730600E-01 |
| Grade 3-vs-Grade 4 |
6.918800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.763100E-04 |
| Normal-vs-ccB subtype |
3.90230000000269E-05 |
| ccA subtype-vs-ccB subtype |
1.491760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07929999999079E-05 |
| Normal-vs-N1 |
3.957700E-03 |
| N0-vs-N1 |
5.770600E-01 |
|
|
